Safety assessment of a newly synthesized copolymer for micellar delivery of hydrophobic caffeic acid phenethyl ester.
Yordan I YordanovDenitsa AluaniVirginia TzankovaStanislav RangelovFeodor OdzhakovAlexandar ApostolovKrassimira YonchevaPublished in: Pharmaceutical development and technology (2020)
Caffeic acid phenethyl ester (CAPE), a major pharmacologically active component of poplar type propolis, is known for its proapoptotic, anti-inflammatory, antioxidant, antiviral, and enzyme inhibiting activities. The aim of this study was to perform an in vitro and in vivo safety assessment of a micellar system based on a newly synthesized copolymer, consisting of polyglycidol and poly(allyl glycidyl ether) (C12-PAGE-PG) as a drug delivery platform for CAPE. The in vitro studies on HepG2 and L929 cells by MTT and LDH assays after treatment with the empty and CAPE-loaded micelles showed no cytotoxic effects of the empty micelles and retained cytotoxic activity of CAPE loaded in the micelles. No hemolysis or stimulation of mouse lymphocytes or macrophages was observed in vitro. In vivo hematological, biochemical, and histological assays on rats, treated with the empty (2580 and 5160 µg/kg) or CAPE-loaded (375 and 750 µg CAPE/kg) micelles did not reveal pathological changes of any of the parameters assayed after 14-days' treatment. In conclusion, initial toxicological data characterize C12-PAGE-PG as a non-toxic and promising copolymer for development of micellar drug delivery systems, particularly for a hydrophobic active substance as CAPE.
Keyphrases
- drug delivery
- south africa
- drug release
- cancer therapy
- anti inflammatory
- high throughput
- signaling pathway
- induced apoptosis
- gene expression
- cell death
- genome wide
- dna methylation
- cell proliferation
- endoplasmic reticulum stress
- cell cycle arrest
- single cell
- artificial intelligence
- deep learning
- pi k akt
- oxide nanoparticles